AN adult onset novel disorder of peroxisomal function is described, characterised by retinitis pigmentosa resulting in progressive visual failure, learning difficulties, a peripheral neuropathy, and hypogonadism. The defect results in accumulation of pristanic acid, and the bile acid intermediates, dihydroxycholestanoic and trihydroxycholestanoic acid, and is due to a deficiency of alpha-methylacyl-CoA racemase, making this the first fully characterised description of this defect. Screening of patients with retinitis pigmentosa should be extended to include pristanic acid and/or bile acid intermediate concentrations, as dietary measures offer a potential treatment for the disorder.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737782 | PMC |
| http://dx.doi.org/10.1136/jnnp.72.3.396 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Zellweger spectrum disorder presenting with opsoclonus-myoclonus-ataxia syndrome: a case report on immunotherapy.
Acta Neurol Belg
January 2025
Department of Pediatrics, Neurology Unit, University of Health Sciences, Ankara Etlik City Hospital, Ankara, Turkey.
Introduction: Zellweger spectrum disorder (ZSD) refers to a group of autosomal recessive genetic disorders that affect multiple organ systems and are predominantly caused by pathogenic variants in PEX genes. ZSD present a wide clinical spectrum, ranging from the most severe form, Zellweger syndrome, to the mildest form, Heimler syndrome.
Case Report: A 14-month-old male patient was brought to our clinic with recent-onset ocular tremors and unsteady gait.
Variable clinical phenotypes of alpha-methylacyl-CoA racemase deficiency: Report of four cases and review of the literature.
JIMD Rep
September 2024
Department of Rare Diseases, Institute of Graduate Studies in Health Sciences Istanbul University Istanbul Turkey.
Alpha-methylacyl-CoA-racemase (AMACR) deficiency (MIM#604489) is a peroxisomal disorder resulting in the accumulation of pristanic acid, dihydroxycholestanoic acid (DHCA), and trihydroxycholestanoic acid (THCA), with variable clinical features and age of onset from infancy to late adulthood. The purpose of this report is to define clinical variations and follow-up data in AMACR deficiency emphasizing treatment with a review of cases reported in the literature. Here, four patients, from two families, diagnosed with AMACR deficiency and showing phenotypic heterogeneity are presented.
View Article and Find Full Text PDFMorphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic Cancer.
JAMA Netw Open
October 2024
Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.
Article Synopsis
- - This study explores how Body Mass Index (BMI) and body composition (morphomics) relate to survival rates in patients with metastatic pancreatic ductal adenocarcinoma (PDA), highlighting variability in previous research.
- - Conducted during a phase 3 clinical trial involving 528 patients across multiple countries, the study collected extensive patient data and used imaging to analyze body composition and serum metabolites for better survival predictions.
- - Findings showed that higher BMI (specifically obesity) wasn't linked to overall survival, while an increase in subcutaneous fat was associated with better outcomes, indicating that factors beyond BMI, like body composition, may play a crucial role in patient survival.
Redefining the phenotype of alpha-methylacyl-CoA racemase (AMACR) deficiency.
Orphanet J Rare Dis
September 2024
Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam Leukodystrophy Center, Amsterdam, The Netherlands.
Article Synopsis
- Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare genetic disorder that causes the buildup of toxic bile acids and has been minimally studied, with fewer than 20 documented cases.
- A recent study involving 12 patients revealed that symptoms like retinitis pigmentosa and neurological issues typically develop in adults after a significant delay in diagnosis, with a median age of 56 years at the time of identification.
- The condition presents primarily as a slowly progressive neurological disease, and MRI scans can help identify characteristic brain abnormalities, highlighting the need for better recognition and awareness of AMACR deficiency.
Amelioration of Phytanic Acid-Induced Neurotoxicity by Nutraceuticals: Mechanistic Insights.
Mol Neurobiol
October 2024
Department of Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110 062, India.
Phytanic acid (PA) (3,7,11,15-tetramethylhexadecanoic acid) is a methyl-branched fatty acid that enters the body through food consumption, primarily through red meat, dairy products, and fatty marine foods. The metabolic byproduct of phytol is PA, which is then oxidized by the ruminal microbiota and some marine species. The first methyl group at the 3-position prevents the β-oxidation of branched-chain fatty acid (BCFA).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!